CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,000 | -23.8% | 7,887 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $21,000 | -40.0% | 7,887 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $35,000 | -23.9% | 7,887 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $46,000 | +2.2% | 7,887 | +23.5% | 0.00% | 0.0% |
| Q1 2021 | $45,000 | +45.2% | 6,387 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $31,000 | -16.2% | 6,387 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $37,000 | -14.0% | 6,387 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $43,000 | +72.0% | 6,387 | +61.0% | 0.00% | +100.0% |
| Q1 2020 | $25,000 | -39.0% | 3,967 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $41,000 | +156.2% | 3,967 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $16,000 | -72.9% | 3,967 | 0.0% | 0.00% | -66.7% |
| Q2 2019 | $59,000 | -39.8% | 3,967 | 0.0% | 0.00% | -40.0% |
| Q1 2019 | $98,000 | +38.0% | 3,967 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $71,000 | -39.3% | 3,967 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $117,000 | -35.0% | 3,967 | 0.0% | 0.01% | -44.4% |
| Q2 2018 | $180,000 | -8.6% | 3,967 | +6.5% | 0.01% | 0.0% |
| Q1 2018 | $197,000 | -22.1% | 3,725 | 0.0% | 0.01% | -25.0% |
| Q4 2017 | $253,000 | -10.6% | 3,725 | 0.0% | 0.01% | -7.7% |
| Q3 2017 | $283,000 | -18.9% | 3,725 | 0.0% | 0.01% | -23.5% |
| Q2 2017 | $349,000 | +79.0% | 3,725 | +21.3% | 0.02% | +70.0% |
| Q1 2017 | $195,000 | – | 3,070 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |